Ahai Luvai
Newcastle Upon Tyne, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The importance of identifying pseudohypertriglyceridaemia.
Journal: Annals of clinical biochemistry
Published: November 06, 2025
Update on Investigation and Management of Dyslipidaemias and Cardiovascular Disease Risk.
Journal: British journal of hospital medicine (London, England : 2005)
Published: March 12, 2025
Rare variant genetic landscape of familial chylomicronemia syndrome (FCS) in the United Kingdom.
Journal: Genetics in medicine open
Published: February 14, 2025
Lipid-lowering optimisation for secondary prevention vascular and diabetic foot patients in a pharmacist-led clinic.
Journal: Journal of clinical lipidology
Published: November 10, 2023
Vitamin B12 reference intervals on Beckman, Roche and Siemens analytical platforms.
Journal: Annals of clinical biochemistry
Published: September 05, 2023
Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary-secondary care interface.
Journal: BMJ open gastroenterology
Published: December 07, 2022
Alternative equations for the calculation of LDL cholesterol: Is it time to replace Friedewald?
Journal: Annals of clinical biochemistry
Published: August 08, 2022
Lipoprotein(a): Insights for the Practicing Clinician.
Journal: Journal of clinical medicine
Published: May 25, 2022
Improving the identification of patients with a genetic diagnosis of familial hypercholesterolaemia in primary care: A strategy to achieve the NHS long term plan.
Journal: Atherosclerosis
Published: November 06, 2020
Albumin and calcium reference interval using healthy individuals and a data-mining approach.
Journal: Annals of clinical biochemistry
Published: July 11, 2020
The clinical and laboratory investigation of dysbetalipoproteinemia.
Journal: Critical reviews in clinical laboratory sciences
Published: April 08, 2020
Potential use of PCSK9 inhibitors as a secondary preventative measure for cardiovascular disease following acute coronary syndrome: a UK real-world study.
Journal: Postgraduate medical journal
Published: October 26, 2018
Last Updated: 09/26/2026